Pancreatic Cancer Vaccines With Amazing Results in Phase I
Pancreatic ductal adenocarcinoma is one of the most lethal cancers with a 5 year survival rate of less than 10%. mRNA designer/personalized vaccines are changing this situation. Let's review the results of phase I trials.
Want to get access to DrBeen at low price of $4.99/month? Click here: www.drbeen.com/med-nerd/
Want to support this work?:
Buy me a coffee :-) www.buymeacoffee.com/DrMobeen...
Become my patron: www.patreon.com/mobeensyed?fa...
PayPal: paypal.me/mobeensyed?locale.x...
My substack: mobeensyedmd.substack.com/
#drbeen #koolbeens #HealthPolicy
Disclaimer:
This video is not intended to provide assessment, diagnosis, treatment, or medical advice; it also does not constitute provision of healthcare services. The content provided in this video is for informational and educational purposes only.
Please consult with a physician or healthcare professional regarding any medical or mental health related diagnosis or treatment. No information in this video should ever be considered as a substitute for advice from a healthcare professional.
URL list from Tuesday, Jun. 4 2024 11:37 AM
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches | Radiation Oncology | Full Text
ro-journal.biomedcentral.com/...
NHS England Thousands of NHS patients to access trials of personalised cancer ‘vaccines’
www.england.nhs.uk/2024/05/th...
Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persistence of Immune Response and Delayed Tumor Recurrence in Some Patients with Resected Pancreatic Cancer | BioNTech
investors.biontech.de/news-re...
Investigational mRNA Vaccine Induced Persistent Immune Response in Phase 1 Trial of Patients With Pancreatic Cancer | Memorial Sloan Kettering Cancer Center
www.mskcc.org/news/can-mrna-v...
Trial Design
www.biontech.com/int/en/home/...
Cancer vaccines are having a renaissance | MIT Technology Review
www.technologyreview.com/2024...
NHS England launches scheme to boost signups for personalised cancer vaccine trials | The BMJ
www.bmj.com/content/385/bmj.q....
3 июн 2024